The Asia Pacific Anti-Obesity Drugs Market would witness market growth of 11.6% CAGR during the forecast period (2023-2029).
In recent clinical trials, the latest generation of anti-obesity medications has shown better weight loss outcomes and a safer side effect profile, making them more appealing than older drugs. These therapies replicate the hormones naturally produced by the intestines during the process of eating. Hormones trigger the pancreas to secrete insulin. GLP-1 enhances satiety. Increases gastric retention time. Lowers blood glucose levels. GLP-1 drugs have proven to be beneficial for treating obesity, in addition to their effectiveness in managing diabetes.
Recent research conducted on adolescents with obesity revealed that the medication was equally effective for them. In addition to the reduction of body weight, there are other advantages to consider: Reduced waist size. Reduced inflammation. Reduced hypertension. Lowered levels of cholesterol and triglycerides for improved health, which is expected to increase their adoption among general audience and thereby surge the market growth.
According to the latest national statistics for New Zealand, 10% of the male and 13% of the female population were classified as obese. In comparison, 55% of males and 38% of females were categorized as overweight. Based on international and regional studies, the prevalence of obesity is on the rise. The objectives of Agencies for Nutrition Action include raising awareness about the health consequences of obesity and expanding programs that prioritize obesity prevention. The government's measures to decrease the cases of obesity due to the high rate of illnesses and the utilization and development of various anti-obesity drugs are expected to increase, propelling the market growth in APAC.
The China market dominated the Asia Pacific Anti-Obesity Drugs Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $257.2 million by 2029. The Japan market is estimated to grow a CAGR of 10.9% during (2023 - 2029). Additionally, The India market would experience a CAGR of 12.3% during (2023 - 2029).
Based on Drug Type, the market is segmented into Prescription Drugs and Over The Counter Drugs. Based on Mechanism of Action, the market is segmented into Centrally Acting and Peripherally Acting. Based on Route Of Administration, the market is segmented into Oral Route and Subcutaneous Route. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Anti-Obesity Drugs Market is Projected to reach USD 3.1 Billion by 2029, at a CAGR of 10.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Novo Nordisk A/S, Rhythm Pharmaceuticals, Inc., Gelesis Holdings Inc. (PureTech Health), Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Vivus LLC, CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH) and KVK Tech, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Prescription Drugs
- Over The Counter Drugs
By Mechanism of Action
- Centrally Acting
- Peripherally Acting
By Route Of Administration
- Oral Route
- Subcutaneous Route
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Pfizer, Inc.
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Novo Nordisk A/S
- Rhythm Pharmaceuticals, Inc.
- Gelesis Holdings Inc. (PureTech Health)
- Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
- Vivus LLC
- CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
- KVK Tech, Inc.
TABLE 1 Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 3 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 Asia Pacific Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 7 Asia Pacific Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 9 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 11 Asia Pacific Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 13 Asia Pacific Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 15 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 17 Asia Pacific Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 19 Asia Pacific Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 21 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 23 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 Asia Pacific Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 27 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 29 Asia Pacific Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 31 China Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 32 China Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 33 China Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 34 China Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 35 China Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 36 China Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 37 China Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 38 China Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 39 China Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 China Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 41 Japan Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 42 Japan Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 43 Japan Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 44 Japan Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 45 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 46 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 47 Japan Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 48 Japan Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 49 Japan Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Japan Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 India Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 52 India Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 53 India Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 54 India Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 55 India Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 56 India Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 57 India Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 58 India Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 59 India Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 60 India Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 61 South Korea Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 62 South Korea Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 63 South Korea Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 64 South Korea Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 65 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 66 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 67 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 68 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 69 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 71 Singapore Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 72 Singapore Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 73 Singapore Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 74 Singapore Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 75 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 76 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 77 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 78 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 79 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 80 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 81 Malaysia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 82 Malaysia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 83 Malaysia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 84 Malaysia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 85 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 86 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 87 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 88 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 89 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 90 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 91 Rest of Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 92 Rest of Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 93 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 94 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 95 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 96 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 97 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 98 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 99 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 100 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 101 Key Information – Pfizer, Inc.
TABLE 102 Key Information – Boehringer Ingelheim International GmbH
TABLE 103 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 104 Key information – Novo Nordisk A/S
TABLE 105 Key Information – Rhythm Pharmaceuticals, Inc
TABLE 106 Key Information – Gelesis Holdings Inc.
TABLE 107 Key Information – Currax Pharmaceuticals LLC
TABLE 108 Key Information – Vivus LLC
TABLE 109 Key Information – CHEPLAPHARM Arzneimittel GmbH
TABLE 110 Key Information – KVK Tech, Inc.
List of Figures
FIG 1 Methodology for the research